Prandin får bugspytkirtlen til at producere mere insulin i forbindelse med måltider og anvendes til regulering af type 2- diabetes.
Prandin has been studied in 45 ‘ clinical pharmacology’ studies (looking at how the medicine works in the body) and 16 clinical trials (looking at its effects in treating type 2 diabetes patients).